Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Transplantation"" wg kryterium: Temat


Starter badań:

Tytuł :
Radiation-sparing reduced-intensity unrelated umbilical cord blood transplantation for rare hematological disorders in children.
Autorzy :
Sawada A; Department of Hematology/Oncology, Osaka Women's and Children's Hospital, 840 Murodo, Izumi city, Osaka, 594-1101, Japan. .
Shimizu M; Department of Hematology/Oncology, Osaka Women's and Children's Hospital, 840 Murodo, Izumi city, Osaka, 594-1101, Japan.
Koyama-Sato M; Department of Hematology/Oncology, Osaka Women's and Children's Hospital, 840 Murodo, Izumi city, Osaka, 594-1101, Japan.
Higuchi K; Department of Hematology/Oncology, Osaka Women's and Children's Hospital, 840 Murodo, Izumi city, Osaka, 594-1101, Japan.
Okada Y; Department of Hematology/Oncology, Osaka Women's and Children's Hospital, 840 Murodo, Izumi city, Osaka, 594-1101, Japan.
Goto K; Department of Hematology/Oncology, Osaka Women's and Children's Hospital, 840 Murodo, Izumi city, Osaka, 594-1101, Japan.
Inoue S; Department of Hematology/Oncology, Osaka Women's and Children's Hospital, 840 Murodo, Izumi city, Osaka, 594-1101, Japan.
Yasui M; Department of Hematology/Oncology, Osaka Women's and Children's Hospital, 840 Murodo, Izumi city, Osaka, 594-1101, Japan.
Inoue M; Department of Hematology/Oncology, Osaka Women's and Children's Hospital, 840 Murodo, Izumi city, Osaka, 594-1101, Japan.
Pokaż więcej
Źródło :
International journal of hematology [Int J Hematol] 2022 Feb; Vol. 115 (2), pp. 269-277. Date of Electronic Publication: 2021 Nov 05.
Typ publikacji :
Journal Article
MeSH Terms :
Cord Blood Stem Cell Transplantation*/adverse effects
Cord Blood Stem Cell Transplantation*/methods
Bone Marrow Failure Disorders/*therapy
Fetal Blood/*transplantation
Leukemia/*therapy
Myelodysplastic Syndromes/*therapy
Adolescent ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Male ; Retrospective Studies ; Transplantation Conditioning/adverse effects ; Transplantation Conditioning/methods ; Whole-Body Irradiation/adverse effects ; Whole-Body Irradiation/methods
Czasopismo naukowe
Tytuł :
Donor-transmitted extramedullary acute myeloid leukaemia after living donor kidney transplantation.
Autorzy :
Ghandili S; Department of Oncology, Hematology, Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Kluger MA; III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Leitner T; Department of Oncology, Hematology, Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Grahammer F; III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Kirchner L; Department of Oncology, Hematology, Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Modemann F; Department of Oncology, Hematology, Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Mildred Scheel Cancer Career Center, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Achilles EG; Department of Visceral Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Kreipe HH; Institute of Pathology, Bone Marrow Reference Center, Hannover Medical School, Hanover, Germany.
Klein J; Institute of Human Genetics, Hannover Medical School, Hanover, Germany.
Steinemann D; Institute of Human Genetics, Hannover Medical School, Hanover, Germany.
Wolschke C; Department of Oncology, Hematology, Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Fischer L; Department of Visceral Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Bokemeyer C; Department of Oncology, Hematology, Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Fiedler W; Department of Oncology, Hematology, Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Huber TB; III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Alsdorf WH; Department of Oncology, Hematology, Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Mahmud M; III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Pokaż więcej
Źródło :
British journal of haematology [Br J Haematol] 2022 Jul; Vol. 198 (1), pp. 199-202. Date of Electronic Publication: 2022 Apr 15.
Typ publikacji :
Letter
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Kidney Transplantation*/adverse effects
Leukemia, Myeloid, Acute*/etiology
Leukemia, Myeloid, Acute*/therapy
Sarcoma, Myeloid*
Bone Marrow Transplantation ; Humans ; Living Donors
Opinia redakcyjna
Tytuł :
Transplantation Tolerance through Hematopoietic Chimerism.
Autorzy :
Spitzer TR; From the Departments of Medicine (T.R.S.) and Surgery (D.H.S.), Massachusetts General Hospital, Boston; and the Departments of Medicine and Surgery, Columbia University, New York (D.H.S.).
Sachs DH; From the Departments of Medicine (T.R.S.) and Surgery (D.H.S.), Massachusetts General Hospital, Boston; and the Departments of Medicine and Surgery, Columbia University, New York (D.H.S.).
Pokaż więcej
Źródło :
The New England journal of medicine [N Engl J Med] 2022 Jun 16; Vol. 386 (24), pp. 2332-2333.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Transplantation Chimera*/immunology
Transplantation Tolerance*/immunology
Bone Marrow Transplantation ; Chimerism ; Humans ; Transplantation Conditioning/methods
Opinia redakcyjna
Tytuł :
Long-Term Incidence of Varicella Zoster Virus Disease in Adults Receiving Single-Unit Cord Blood Transplantation.
Autorzy :
Fukushi K; Department of Pharmacy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Konuma T; Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Electronic address: .
Monna-Oiwa M; Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Isobe M; Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Kato S; Division of Clinical Precision Research Platform, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Kuroda S; Department of Pharmacy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Takahashi S; Division of Clinical Precision Research Platform, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Nannya Y; Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Pokaż więcej
Źródło :
Transplantation and cellular therapy [Transplant Cell Ther] 2022 Jun; Vol. 28 (6), pp. 339.e1-339.e7. Date of Electronic Publication: 2022 Mar 29.
Typ publikacji :
Journal Article
MeSH Terms :
Cord Blood Stem Cell Transplantation*/adverse effects
Hematopoietic Stem Cell Transplantation*/adverse effects
Herpes Zoster*/epidemiology
Acyclovir/pharmacology ; Adult ; Antiviral Agents/therapeutic use ; Herpesvirus 3, Human ; Humans ; Incidence ; Retrospective Studies ; Transplantation, Homologous/adverse effects ; Virus Activation
Czasopismo naukowe
Tytuł :
Measuring success in pig to non-human-primate renal xenotransplantation: Systematic review and comparative outcomes analysis of 1051 life-sustaining NHP renal allo- and xeno-transplants.
Autorzy :
Firl DJ; Center for Transplantation Sciences, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Surgery, Duke University Hospital, Durham, North Carolina, USA.
Markmann JF; Center for Transplantation Sciences, Massachusetts General Hospital, Boston, Massachusetts, USA.
Pokaż więcej
Źródło :
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons [Am J Transplant] 2022 Jun; Vol. 22 (6), pp. 1527-1536. Date of Electronic Publication: 2022 Feb 28.
Typ publikacji :
Journal Article; Systematic Review
MeSH Terms :
Kidney Transplantation*/adverse effects
Kidney Transplantation*/methods
Transplants*
Animals ; Graft Rejection/etiology ; Graft Survival ; Heterografts ; Humans ; Macaca mulatta ; Swine ; Transplantation, Heterologous/adverse effects ; Transplantation, Heterologous/methods
Czasopismo naukowe
Tytuł :
Unresolved issues in allogeneic hematopoietic cell transplantation for non-malignant diseases.
Autorzy :
Umeda K; Department of Pediatrics, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan. .
Pokaż więcej
Źródło :
International journal of hematology [Int J Hematol] 2022 Jul; Vol. 116 (1), pp. 41-47. Date of Electronic Publication: 2022 May 14.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Graft vs Host Disease*/etiology
Graft vs Host Disease*/prevention & control
Hematologic Neoplasms*/complications
Hematopoietic Stem Cell Transplantation*/adverse effects
Humans ; Quality of Life ; Transplantation Conditioning/adverse effects ; Transplantation, Homologous/adverse effects
Czasopismo naukowe
Tytuł :
Salvage High-dose Melphalan With Autologous Stem cell Transplantation as Bridge to Consolidation Therapy for Chemoresistant Aggressive B-cell Lymphoma.
Autorzy :
Kaddu-Mulindwa D; Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Medical School, University of Saarland, Germany. Electronic address: .
Gödel P; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne Essen Lymphoma Working Group.
Kutsch N; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne Essen Lymphoma Working Group.
Heger JM; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne Essen Lymphoma Working Group.
Scheid C; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne Essen Lymphoma Working Group.
Borchmann P; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne Essen Lymphoma Working Group.
Holtick U; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne Essen Lymphoma Working Group.
Held G; Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Medical School, University of Saarland, Germany.
Thurner L; Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Medical School, University of Saarland, Germany.
Bewarder M; Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Medical School, University of Saarland, Germany.
Rixecker T; Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Medical School, University of Saarland, Germany.
Bittenbring JT; Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Medical School, University of Saarland, Germany; Department of Hematology, Oncology, Clinical Immunology, Rheumatology, Medical School, University of Saarland, Germany.
Pokaż więcej
Źródło :
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2022 Jul; Vol. 22 (7), pp. e498-e506. Date of Electronic Publication: 2022 Jan 13.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Hematopoietic Stem Cell Transplantation*/methods
Lymphoma*/drug therapy
Lymphoma, B-Cell*/drug therapy
Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Consolidation Chemotherapy ; Humans ; Melphalan/therapeutic use ; Neoplasm Recurrence, Local/drug therapy ; Retrospective Studies ; Salvage Therapy/methods ; Stem Cell Transplantation ; Transplantation, Autologous
Czasopismo naukowe
Tytuł :
[Strategy Optimization and Clinical Analyze of Multiple Nucleotide Polymorphism Analysis in the Chimerism Detection after Allogeneic Hematopoietic Stem Cell Transplantation].
Autorzy :
Zou Z; Central Laboratory, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, Henan Province, China.
Sun R; Central Laboratory, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, Henan Province, China.
Li YW; Central Laboratory, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, Henan Province, China.
Guo Z; Central Laboratory, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, Henan Province, China.
Fan RH; Central Laboratory, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, Henan Province, China.
Lyu XD; Central Laboratory, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, Henan Province, China,E-mail:.
Pokaż więcej
Źródło :
Zhongguo shi yan xue ye xue za zhi [Zhongguo Shi Yan Xue Ye Xue Za Zhi] 2022 Jun; Vol. 30 (3), pp. 913-918.
Typ publikacji :
Journal Article
MeSH Terms :
Chimerism*
Hematopoietic Stem Cell Transplantation*
Humans ; Nucleotides ; Reproducibility of Results ; Retrospective Studies ; Transplantation Chimera/genetics ; Transplantation, Homologous
Czasopismo naukowe
Tytuł :
Journey of a Patient With Multiple Myeloma Undergoing Autologous Stem Cell Transplantation.
Autorzy :
Chong CY; City of Hope National Medical Center.
Pokaż więcej
Źródło :
Clinical journal of oncology nursing [Clin J Oncol Nurs] 2022 Jun 01; Vol. 26 (3), pp. 252-256.
Typ publikacji :
Journal Article
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Multiple Myeloma*/drug therapy
Humans ; Stem Cell Transplantation ; Transplantation, Autologous
Czasopismo naukowe
Tytuł :
Relapse with plasmacytoma after upfront autologous stem cell transplantation in multiple myeloma.
Autorzy :
Chu TH; BioMedical Sciences Graduate Program, Chonnam National University, Gwangju, Republic of Korea.; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital and Chonnam National University Medical School, 322 Seoyangro, Hwasun, Jeollanamdo, Seoul, 58128, Republic of Korea.
Jung SH; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital and Chonnam National University Medical School, 322 Seoyangro, Hwasun, Jeollanamdo, Seoul, 58128, Republic of Korea.
Kim K; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Lee JH; Gachon University Gil Medical Center, Incheon, Republic of Korea.
Mun YC; Ewha Womans University School of Medicine, Seoul, Republic of Korea.
Bang SM; Seoul National University Bundang Hospital, Seoul, Republic of Korea.
Yoon DH; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Lee HS; Kosin University Gospel Hospital, Busan, Republic of Korea.
Min CK; Department of Hematology, College of Medicine, Seoul St. Mary's Hematology Hospital, The Catholic University of Korea, 222 Banpodaero, Seocho-gu, Seoul, 137-070, Republic of Korea. .
Lee JJ; BioMedical Sciences Graduate Program, Chonnam National University, Gwangju, Republic of Korea. .; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital and Chonnam National University Medical School, 322 Seoyangro, Hwasun, Jeollanamdo, Seoul, 58128, Republic of Korea. .
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2022 Jun; Vol. 101 (6), pp. 1217-1226. Date of Electronic Publication: 2022 Apr 21.
Typ publikacji :
Journal Article
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Multiple Myeloma*
Plasmacytoma*/therapy
Humans ; Neoplasm Recurrence, Local/therapy ; Retrospective Studies ; Stem Cell Transplantation ; Transplantation, Autologous
Czasopismo naukowe
Tytuł :
Salvage Cord Blood Transplantation Using a Short-term Reduced-intensity Conditioning Regimen for Graft Failure.
Autorzy :
Suma S; Department of Hematology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Japan.
Yokoyama Y; Department of Hematology, Faculty of Medicine, University of Tsukuba, Japan.; Department of Hematology, University of Tsukuba Hospital, Japan.
Momose H; Department of Hematology, University of Tsukuba Hospital, Japan.
Makishima K; Department of Hematology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Japan.
Kiyoki Y; Department of Hematology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Japan.
Sakamoto T; Department of Hematology, Faculty of Medicine, University of Tsukuba, Japan.; Department of Hematology, University of Tsukuba Hospital, Japan.
Kusakabe M; Department of Hematology, Faculty of Medicine, University of Tsukuba, Japan.; Department of Hematology, University of Tsukuba Hospital, Japan.
Kato T; Department of Hematology, Faculty of Medicine, University of Tsukuba, Japan.; Department of Hematology, University of Tsukuba Hospital, Japan.
Kurita N; Department of Hematology, Faculty of Medicine, University of Tsukuba, Japan.; Department of Hematology, University of Tsukuba Hospital, Japan.
Nishikii H; Department of Hematology, Faculty of Medicine, University of Tsukuba, Japan.; Department of Hematology, University of Tsukuba Hospital, Japan.
Sakata-Yanagimoto M; Department of Hematology, Faculty of Medicine, University of Tsukuba, Japan.; Department of Hematology, University of Tsukuba Hospital, Japan.
Obara N; Department of Hematology, Faculty of Medicine, University of Tsukuba, Japan.; Department of Hematology, University of Tsukuba Hospital, Japan.
Hasegawa Y; Department of Hematology, Ibaraki Prefecture Central Hospital, Japan.
Chiba S; Department of Hematology, Faculty of Medicine, University of Tsukuba, Japan.; Department of Hematology, University of Tsukuba Hospital, Japan.
Pokaż więcej
Źródło :
Internal medicine (Tokyo, Japan) [Intern Med] 2022 Jun 01; Vol. 61 (11), pp. 1673-1679. Date of Electronic Publication: 2021 Nov 20.
Typ publikacji :
Journal Article
MeSH Terms :
Cord Blood Stem Cell Transplantation*
Graft vs Host Disease*/etiology
Hematopoietic Stem Cell Transplantation*/adverse effects
Humans ; Retrospective Studies ; Salvage Therapy/methods ; Transplantation Conditioning/methods ; Vidarabine/therapeutic use
Czasopismo naukowe
Tytuł :
Variable impact of graft CD3 cells overestimated?
Autorzy :
Yegin ZA; Gazi University Faculty of Medicine, Department of Hematology, Ankara, Turkey. Electronic address: .
Bostankolu Değirmenci B; Gazi University Faculty of Medicine, Department of Hematology, Ankara, Turkey.
Yazıcı Şener G; Gazi University Faculty of Medicine, Department of Internal Medicine, Ankara, Turkey.
Savaş EM; Gazi University Faculty of Medicine, Department of Hematology, Ankara, Turkey.
Özkurt ZN; Gazi University Faculty of Medicine, Department of Hematology, Ankara, Turkey.
Koç HN; Gazi University Faculty of Medicine, Department of Internal Medicine, Ankara, Turkey.
İlhan Ç; Gazi University Faculty of Medicine, Department of Hematology, Ankara, Turkey.
Pokaż więcej
Źródło :
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis [Transfus Apher Sci] 2022 Jun; Vol. 61 (3), pp. 103349. Date of Electronic Publication: 2021 Dec 29.
Typ publikacji :
Journal Article
MeSH Terms :
Graft vs Host Disease*
Hematopoietic Stem Cell Transplantation*/adverse effects
Adult ; Female ; Humans ; Male ; Recurrence ; Retrospective Studies ; Transplantation Conditioning/adverse effects ; Transplantation, Homologous/adverse effects
Czasopismo naukowe
Tytuł :
Current Status and Perspectives of Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients with Acute Myeloid Leukemia.
Autorzy :
Sophie S; Department of Clinical Hematology, CHU of Liège, Liège, Belgium.; Hematology Research Unit GIGA-I3, University of Liège, Liège, Belgium.
Yves B; Department of Clinical Hematology, CHU of Liège, Liège, Belgium.; Hematology Research Unit GIGA-I3, University of Liège, Liège, Belgium.
Frédéric B; Department of Clinical Hematology, CHU of Liège, Liège, Belgium.; Hematology Research Unit GIGA-I3, University of Liège, Liège, Belgium.
Pokaż więcej
Źródło :
Stem cells translational medicine [Stem Cells Transl Med] 2022 May 27; Vol. 11 (5), pp. 461-477.
Typ publikacji :
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms :
Graft vs Host Disease*
Hematopoietic Stem Cell Transplantation*
Leukemia, Myeloid, Acute*/therapy
Aged ; Humans ; Transplantation Conditioning ; Transplantation, Homologous
Czasopismo naukowe
Tytuł :
Impact of risk scores in outcome of patients with myeloid neoplasms after allogeneic stem cell transplant.
Autorzy :
Fernández-Caballero M; Servicio de Hematología, Institut Català d'Oncologia, Institut de Recerca contra la Leucèmia Josep Carreras, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain. Electronic address: .
Jiménez Lorenzo MJ; Servicio de Hematología, Institut Català d'Oncologia, Institut de Recerca contra la Leucèmia Josep Carreras, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.
Morgades de la Fe M; Servicio de Hematología, Institut Català d'Oncologia, Institut de Recerca contra la Leucèmia Josep Carreras, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.
Ferrà Coll C; Servicio de Hematología, Institut Català d'Oncologia, Institut de Recerca contra la Leucèmia Josep Carreras, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.
Vives Polo S; Servicio de Hematología, Institut Català d'Oncologia, Institut de Recerca contra la Leucèmia Josep Carreras, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.
Abril Sabater L; Servicio de Hematología, Institut Català d'Oncologia, Institut de Recerca contra la Leucèmia Josep Carreras, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.
Navarro Ferrando JT; Servicio de Hematología, Institut Català d'Oncologia, Institut de Recerca contra la Leucèmia Josep Carreras, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.
Ribera Santasusana JM; Servicio de Hematología, Institut Català d'Oncologia, Institut de Recerca contra la Leucèmia Josep Carreras, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain.
Pokaż więcej
Źródło :
Medicina clinica [Med Clin (Barc)] 2022 May 27; Vol. 158 (10), pp. 451-457. Date of Electronic Publication: 2021 Aug 14.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Leukemia, Myeloid, Acute*/therapy
Myelodysplastic Syndromes*/therapy
Myeloproliferative Disorders*
Humans ; Recurrence ; Retrospective Studies ; Risk Factors ; Transplantation Conditioning ; Transplantation, Homologous
Czasopismo naukowe
Tytuł :
Outcomes linked to eligibility for stem cell transplantation trials in diffuse cutaneous systemic sclerosis.
Autorzy :
Spierings J; Division of Medicine, Department of Inflammation, Centre for Rheumatology and Connective Tissue Diseases, Royal Free and University College Medical School, University College London, London, UK.; Department of Rheumatology and Clinical Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands.
Nihtyanova SI; Division of Medicine, Department of Inflammation, Centre for Rheumatology and Connective Tissue Diseases, Royal Free and University College Medical School, University College London, London, UK.
Derrett-Smith E; Division of Medicine, Department of Inflammation, Centre for Rheumatology and Connective Tissue Diseases, Royal Free and University College Medical School, University College London, London, UK.
Clark KEN; Division of Medicine, Department of Inflammation, Centre for Rheumatology and Connective Tissue Diseases, Royal Free and University College Medical School, University College London, London, UK.
van Laar JM; Department of Rheumatology and Clinical Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands.
Ong V; Division of Medicine, Department of Inflammation, Centre for Rheumatology and Connective Tissue Diseases, Royal Free and University College Medical School, University College London, London, UK.
Denton CP; Division of Medicine, Department of Inflammation, Centre for Rheumatology and Connective Tissue Diseases, Royal Free and University College Medical School, University College London, London, UK.
Pokaż więcej
Źródło :
Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2022 May 05; Vol. 61 (5), pp. 1948-1956.
Typ publikacji :
Journal Article
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Hypertension, Pulmonary*/etiology
Scleroderma, Diffuse*/drug therapy
Scleroderma, Systemic*/drug therapy
Aged ; Dihydrotachysterol/therapeutic use ; Humans ; Male ; Stem Cell Transplantation ; Transplantation, Autologous
Czasopismo naukowe
Tytuł :
Differences in Protein Secretion by Multipotent Mesenchymal Stromal Cells Effective and Ineffective in the Prevention of Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Autorzy :
Petinati NA; National Medical Research Center of Hematology, Ministry of Health of the Russian Federation, Moscow, Russia. .
Drize NI; National Medical Research Center of Hematology, Ministry of Health of the Russian Federation, Moscow, Russia.
Arapidi GP; National Medical Research Center of Hematology, Ministry of Health of the Russian Federation, Moscow, Russia.
Shender VO; National Medical Research Center of Hematology, Ministry of Health of the Russian Federation, Moscow, Russia.
Lagar'kova MA; National Medical Research Center of Hematology, Ministry of Health of the Russian Federation, Moscow, Russia.
Kuz'mina LA; National Medical Research Center of Hematology, Ministry of Health of the Russian Federation, Moscow, Russia.
Parovichnikova EN; National Medical Research Center of Hematology, Ministry of Health of the Russian Federation, Moscow, Russia.
Savchenko VG; National Medical Research Center of Hematology, Ministry of Health of the Russian Federation, Moscow, Russia.
Pokaż więcej
Źródło :
Bulletin of experimental biology and medicine [Bull Exp Biol Med] 2022 May; Vol. 173 (1), pp. 128-132. Date of Electronic Publication: 2022 May 27.
Typ publikacji :
Journal Article
MeSH Terms :
Graft vs Host Disease*/prevention & control
Hematopoietic Stem Cell Transplantation*/adverse effects
Mesenchymal Stem Cell Transplantation*
Mesenchymal Stem Cells*
Humans ; Transplantation, Homologous
Czasopismo naukowe
Tytuł :
Improving allogeneic stem cell transplantation in myelofibrosis.
Autorzy :
Gagelmann N; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Martinistr 52, 20246, Hamburg, Germany.
Kröger N; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Martinistr 52, 20246, Hamburg, Germany. .
Pokaż więcej
Źródło :
International journal of hematology [Int J Hematol] 2022 May; Vol. 115 (5), pp. 619-625. Date of Electronic Publication: 2022 Apr 13.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Hematologic Neoplasms*/etiology
Hematopoietic Stem Cell Transplantation*/adverse effects
Primary Myelofibrosis*/genetics
Primary Myelofibrosis*/therapy
Humans ; Neoplasm Recurrence, Local/etiology ; Transplantation Conditioning/methods ; Transplantation, Homologous
Czasopismo naukowe
Tytuł :
Improving Safety and Outcomes After Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience.
Autorzy :
Salas MQ; Department of Medicine, University of Toronto, Toronto, Canada; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network. Toronto, Canada; Bone Marrow Transplant Unit, Department of Hematology, IDIBAPS, Hospital Clinic de Barcelona, Spain.
Pasic I; Department of Medicine, University of Toronto, Toronto, Canada; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network. Toronto, Canada.
Remberger M; Department of Medical Sciences, Uppsala University and KFUE, Uppsala University Hospital, Uppsala, Sweden.
Novitzky-Basso I; Department of Medicine, University of Toronto, Toronto, Canada; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network. Toronto, Canada.
Law AD; Department of Medicine, University of Toronto, Toronto, Canada; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network. Toronto, Canada.
Lam W; Department of Medicine, University of Toronto, Toronto, Canada; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network. Toronto, Canada.
Chen C; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network. Toronto, Canada.
Kim DDH; Department of Medicine, University of Toronto, Toronto, Canada; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network. Toronto, Canada.
Michelis FV; Department of Medicine, University of Toronto, Toronto, Canada; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network. Toronto, Canada.
Gerbitz A; Department of Medicine, University of Toronto, Toronto, Canada; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network. Toronto, Canada.
Viswabandya A; Department of Medicine, University of Toronto, Toronto, Canada; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network. Toronto, Canada.
Lipton JH; Department of Medicine, University of Toronto, Toronto, Canada; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network. Toronto, Canada.
Kumar R; Department of Medicine, University of Toronto, Toronto, Canada; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network. Toronto, Canada.
Mattsson J; Department of Medicine, University of Toronto, Toronto, Canada; Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network. Toronto, Canada; Gloria and Seymour Epstein Chair in Cell Therapy and Transplantation, Department of Medicine, University of Toronto, Toronto, Canada. Electronic address: .
Pokaż więcej
Źródło :
Transplantation and cellular therapy [Transplant Cell Ther] 2022 May; Vol. 28 (5), pp. 265.e1-265.e9. Date of Electronic Publication: 2022 Feb 06.
Typ publikacji :
Journal Article
MeSH Terms :
Graft vs Host Disease*/prevention & control
Hematopoietic Stem Cell Transplantation*/adverse effects
Adult ; Antilymphocyte Serum/therapeutic use ; Cyclosporine/therapeutic use ; Humans ; Transplantation Conditioning/adverse effects ; Transplantation, Homologous/adverse effects
Czasopismo naukowe
Tytuł :
Total body irradiation-based versus busulfan-based myeloablative conditioning for single-unit cord blood transplantation in adults.
Autorzy :
Konuma T; Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Ooi J; Department of Health and Nutrition, University of Human Arts and Sciences, Saitama, Japan.
Monna-Oiwa M; Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Isobe M; Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Tomonari A; Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Kato S; Department of Hematology, Yokohama Minami Kyousai Hospital, Yokohama, Japan.
Iseki T; Department of Transfusion Medicine and Cell Therapy, Chiba University Hospital, Chiba, Japan.
Nannya Y; Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Tojo A; Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Takahashi S; Division of Clinical Precision Research Platform, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Pokaż więcej
Źródło :
Leukemia & lymphoma [Leuk Lymphoma] 2022 May; Vol. 63 (5), pp. 1191-1201. Date of Electronic Publication: 2021 Dec 23.
Typ publikacji :
Journal Article
MeSH Terms :
Cord Blood Stem Cell Transplantation*/adverse effects
Cord Blood Stem Cell Transplantation*/methods
Graft vs Host Disease*/etiology
Graft vs Host Disease*/prevention & control
Hematopoietic Stem Cell Transplantation*
Adult ; Busulfan/therapeutic use ; Humans ; Myeloablative Agonists/therapeutic use ; Retrospective Studies ; Transplantation Conditioning/methods ; Whole-Body Irradiation
Czasopismo naukowe
Tytuł :
Oral chronic GVHD after allogeneic stem cell transplantation without total body irradiation performed at a young age.
Autorzy :
Tanem KE; Department of Oral Surgery and Oral Medicine, Faculty of Dentistry, University of Oslo, Postbox 1109 Blindern, N-0317, Oslo, Norway. .
Wilberg P; Department of Oral Surgery and Oral Medicine, Faculty of Dentistry, University of Oslo, Postbox 1109 Blindern, N-0317, Oslo, Norway.
Diep PP; Department of Pediatric Oncology and Hematology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Ruud E; Department of Pediatric Oncology and Hematology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Skaare AB; Department of Pediatric Dentistry and Behavioral Science, Faculty of Dentistry, University of Oslo, Oslo, Norway.
Brinch L; Department of Hematology, Oslo University Hospital, Oslo, Norway.
Herlofson BB; Department of Oral Surgery and Oral Medicine, Faculty of Dentistry, University of Oslo, Postbox 1109 Blindern, N-0317, Oslo, Norway.; Unit of Oral and Maxillofacial Surgery, Division for Head, Neck, and Reconstructive Surgery, Department of Otorhinolaryngology, Oslo University Hospital, Oslo, Norway.
Pokaż więcej
Źródło :
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2022 May; Vol. 30 (5), pp. 4121-4128. Date of Electronic Publication: 2022 Jan 24.
Typ publikacji :
Journal Article
MeSH Terms :
Graft vs Host Disease*/pathology
Hematopoietic Stem Cell Transplantation*/adverse effects
Adolescent ; Adult ; Child ; Child, Preschool ; Chronic Disease ; Humans ; Infant ; Survivors ; Transplantation Conditioning/adverse effects ; Transplantation, Homologous/adverse effects ; Whole-Body Irradiation/adverse effects ; Young Adult
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies